Matches in Nanopublications for { ?s ?p "[Influence of CYP3A5 and drug transporter polymorphisms on imatinib trough concentration and clinical response among patients with chronic phase chronic myeloid leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 7 of
7
with 100 items per page.
- NP471302.RAhZDQ6TJppNxxMhcTVKjNl467KiOBj8es6E5n4YiB9ac130_assertion description "[Influence of CYP3A5 and drug transporter polymorphisms on imatinib trough concentration and clinical response among patients with chronic phase chronic myeloid leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP471302.RAhZDQ6TJppNxxMhcTVKjNl467KiOBj8es6E5n4YiB9ac130_provenance.
- NP88781.RAK7_P5mVPDJOWQFzppYpJmHmhpiF4F19m4kdC972FFc0130_assertion description "[Influence of CYP3A5 and drug transporter polymorphisms on imatinib trough concentration and clinical response among patients with chronic phase chronic myeloid leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP88781.RAK7_P5mVPDJOWQFzppYpJmHmhpiF4F19m4kdC972FFc0130_provenance.
- NP343768.RA4JPLbixUv2oeUH2wW--8Ya5y0_V_LaBoCIAaa5R8-xQ130_assertion description "[Influence of CYP3A5 and drug transporter polymorphisms on imatinib trough concentration and clinical response among patients with chronic phase chronic myeloid leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP343768.RA4JPLbixUv2oeUH2wW--8Ya5y0_V_LaBoCIAaa5R8-xQ130_provenance.
- assertion description "[Influence of CYP3A5 and drug transporter polymorphisms on imatinib trough concentration and clinical response among patients with chronic phase chronic myeloid leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP142431.RAtW4uXJ5mNUSWhckBTKPqlqpD1BCNE55EcbCFnzNB3VU130_assertion description "[Influence of CYP3A5 and drug transporter polymorphisms on imatinib trough concentration and clinical response among patients with chronic phase chronic myeloid leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP142431.RAtW4uXJ5mNUSWhckBTKPqlqpD1BCNE55EcbCFnzNB3VU130_provenance.
- NP183921.RAHF8mkQBY3oD9FTCiGZ4xRZLRhUrMjyheJnF9Cv6Hmv8130_assertion description "[Influence of CYP3A5 and drug transporter polymorphisms on imatinib trough concentration and clinical response among patients with chronic phase chronic myeloid leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP183921.RAHF8mkQBY3oD9FTCiGZ4xRZLRhUrMjyheJnF9Cv6Hmv8130_provenance.
- NP833642.RAldW6IW2LewmWxiR39iZoYbqf-yewBM3bGdegWKA3WVE130_assertion description "[Influence of CYP3A5 and drug transporter polymorphisms on imatinib trough concentration and clinical response among patients with chronic phase chronic myeloid leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP833642.RAldW6IW2LewmWxiR39iZoYbqf-yewBM3bGdegWKA3WVE130_provenance.